Do analysts rate MGIH or ISPC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Millennium Group International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 iSpecimen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation & earnings, MGIH or ISPC?

Millennium Group International has higher revenue and earnings than iSpecimen. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Millennium Group International $25.33M 0.72 -$6.32M N/A N/A iSpecimen $1.93M 2.05 -$10.49M -$72.26 N/A

Do analysts prefer IPM or ISPC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Intelligent Protection Management 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 iSpecimen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer ISPC or TGHL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iSpecimen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 GrowHub 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, ISPC or TGHL?

iSpecimen has higher revenue and earnings than GrowHub. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio iSpecimen $1.93M 2.05 -$10.49M -$72.26 N/A GrowHub $60K 228.54 -$13.38M N/A N/A

Is ISPC or TGHL more profitable?

GrowHub has a net margin of 0.00% compared to iSpecimen's net margin of -1,080.16%. GrowHub's return on equity of 0.00% beat iSpecimen's return on equity. Company Net Margins Return on Equity Return on Assets iSpecimen -1,080.16% -584.65% -142.48% GrowHub N/A N/A N/A

Do analysts prefer TC or ISPC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Token Cat 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 iSpecimen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings & valuation, TC or ISPC?

Token Cat has higher earnings, but lower revenue than iSpecimen. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Token Cat $850K 19.34 $320K N/A N/A iSpecimen $1.93M 2.05 -$10.49M -$72.26 N/A

Is TC or ISPC more profitable?

Token Cat has a net margin of 0.00% compared to iSpecimen's net margin of -1,080.16%. Token Cat's return on equity of 0.00% beat iSpecimen's return on equity. Company Net Margins Return on Equity Return on Assets Token Cat N/A N/A N/A iSpecimen -1,080.16% -584.65% -142.48%

Do analysts recommend ISPC or MOGU?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iSpecimen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 MOGU 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings and valuation, ISPC or MOGU?

MOGU has higher revenue and earnings than iSpecimen. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio iSpecimen $1.93M 2.05 -$10.49M -$72.26 N/A MOGU $19.46M 0.70 -$8.62M N/A N/A

Is ISPC or MOGU more profitable?

MOGU has a net margin of 0.00% compared to iSpecimen's net margin of -1,080.16%. MOGU's return on equity of 0.00% beat iSpecimen's return on equity. Company Net Margins Return on Equity Return on Assets iSpecimen -1,080.16% -584.65% -142.48% MOGU N/A N/A N/A

iSpecimen (ISPC) Competitors

$2.75 0.00 (0.00%)

Closing price 06/12/2026 04:00 PM Eastern

Extended Trading

$2.83 +0.08 (+2.87%)

As of 06/12/2026 07:57 PM Eastern

Compare

ISPC vs. MGIH, IPM, TGHL, TC, and MOGU

Should you buy iSpecimen stock or one of its competitors? MarketBeat compares iSpecimen with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with iSpecimen include Millennium Group International (MGIH), Intelligent Protection Management (IPM), GrowHub (TGHL), Token Cat (TC), and MOGU (MOGU). These companies are all part of the "business services" industry.

How does iSpecimen compare to Millennium Group International?

Millennium Group International (NASDAQ:MGIH) and iSpecimen (NASDAQ:ISPC) are both small-cap business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, media sentiment, analyst recommendations, profitability, earnings, dividends and institutional ownership.

Millennium Group International has a net margin of 0.00% compared to iSpecimen's net margin of -1,080.16%. Millennium Group International's return on equity of 0.00% beat iSpecimen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Millennium Group International	N/A	N/A	N/A
iSpecimen	-1,080.16%	-584.65%	-142.48%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Millennium Group International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
iSpecimen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Millennium Group International and Millennium Group International both had 2 articles in the media. Millennium Group International's average media sentiment score of 1.44 beat iSpecimen's score of 0.44 indicating that Millennium Group International is being referred to more favorably in the media.

Company	Overall Sentiment
Millennium Group International	Positive
iSpecimen	Neutral

Millennium Group International has higher revenue and earnings than iSpecimen.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Millennium Group International	$25.33M	0.72	-$6.32M	N/A	N/A
iSpecimen	$1.93M	2.05	-$10.49M	-$72.26	N/A

Millennium Group International has a beta of 0.91, suggesting that its stock price is 9% less volatile than the broader market. Comparatively, iSpecimen has a beta of 1.62, suggesting that its stock price is 62% more volatile than the broader market.

0.3% of Millennium Group International shares are owned by institutional investors. Comparatively, 13.6% of iSpecimen shares are owned by institutional investors. 12.2% of iSpecimen shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Millennium Group International beats iSpecimen on 6 of the 10 factors compared between the two stocks.

How does iSpecimen compare to Intelligent Protection Management?

Intelligent Protection Management (NASDAQ:IPM) and iSpecimen (NASDAQ:ISPC) are both small-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation, media sentiment and analyst recommendations.

Intelligent Protection Management has a beta of 0.45, indicating that its stock price is 55% less volatile than the broader market. Comparatively, iSpecimen has a beta of 1.62, indicating that its stock price is 62% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intelligent Protection Management	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
iSpecimen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

3.9% of Intelligent Protection Management shares are owned by institutional investors. Comparatively, 13.6% of iSpecimen shares are owned by institutional investors. 20.8% of Intelligent Protection Management shares are owned by insiders. Comparatively, 12.2% of iSpecimen shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Intelligent Protection Management has a net margin of -14.01% compared to iSpecimen's net margin of -1,080.16%. Intelligent Protection Management's return on equity of -18.44% beat iSpecimen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intelligent Protection Management	-14.01%	-18.44%	-12.16%
iSpecimen	-1,080.16%	-584.65%	-142.48%

In the previous week, Intelligent Protection Management had 4 more articles in the media than iSpecimen. MarketBeat recorded 6 mentions for Intelligent Protection Management and 2 mentions for iSpecimen. Intelligent Protection Management's average media sentiment score of 1.13 beat iSpecimen's score of 0.44 indicating that Intelligent Protection Management is being referred to more favorably in the media.

Company	Overall Sentiment
Intelligent Protection Management	Positive
iSpecimen	Neutral

Intelligent Protection Management has higher revenue and earnings than iSpecimen. Intelligent Protection Management is trading at a lower price-to-earnings ratio than iSpecimen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intelligent Protection Management	$23.61M	0.71	-$1.96M	-$0.26	N/A
iSpecimen	$1.93M	2.05	-$10.49M	-$72.26	N/A

Summary

Intelligent Protection Management beats iSpecimen on 9 of the 13 factors compared between the two stocks.

How does iSpecimen compare to GrowHub?

iSpecimen (NASDAQ:ISPC) and GrowHub (NASDAQ:TGHL) are both small-cap business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, media sentiment, valuation and earnings.

GrowHub has a net margin of 0.00% compared to iSpecimen's net margin of -1,080.16%. GrowHub's return on equity of 0.00% beat iSpecimen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iSpecimen	-1,080.16%	-584.65%	-142.48%
GrowHub	N/A	N/A	N/A

iSpecimen has higher revenue and earnings than GrowHub.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iSpecimen	$1.93M	2.05	-$10.49M	-$72.26	N/A
GrowHub	$60K	228.54	-$13.38M	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iSpecimen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
GrowHub	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, GrowHub had 4 more articles in the media than iSpecimen. MarketBeat recorded 6 mentions for GrowHub and 2 mentions for iSpecimen. GrowHub's average media sentiment score of 0.49 beat iSpecimen's score of 0.44 indicating that GrowHub is being referred to more favorably in the news media.

Company	Overall Sentiment
iSpecimen	Neutral
GrowHub	Neutral

13.6% of iSpecimen shares are owned by institutional investors. 12.2% of iSpecimen shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

GrowHub beats iSpecimen on 6 of the 10 factors compared between the two stocks.

How does iSpecimen compare to Token Cat?

Token Cat (NASDAQ:TC) and iSpecimen (NASDAQ:ISPC) are both small-cap business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, analyst recommendations, dividends, profitability, valuation, risk and earnings.

Token Cat has a net margin of 0.00% compared to iSpecimen's net margin of -1,080.16%. Token Cat's return on equity of 0.00% beat iSpecimen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Token Cat	N/A	N/A	N/A
iSpecimen	-1,080.16%	-584.65%	-142.48%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Token Cat	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
iSpecimen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Token Cat has a beta of 0.63, meaning that its share price is 37% less volatile than the broader market. Comparatively, iSpecimen has a beta of 1.62, meaning that its share price is 62% more volatile than the broader market.

Token Cat has higher earnings, but lower revenue than iSpecimen.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Token Cat	$850K	19.34	$320K	N/A	N/A
iSpecimen	$1.93M	2.05	-$10.49M	-$72.26	N/A

In the previous week, iSpecimen had 1 more articles in the media than Token Cat. MarketBeat recorded 2 mentions for iSpecimen and 1 mentions for Token Cat. Token Cat's average media sentiment score of 1.89 beat iSpecimen's score of 0.44 indicating that Token Cat is being referred to more favorably in the media.

Company	Overall Sentiment
Token Cat	Very Positive
iSpecimen	Neutral

8.9% of Token Cat shares are held by institutional investors. Comparatively, 13.6% of iSpecimen shares are held by institutional investors. 0.5% of Token Cat shares are held by company insiders. Comparatively, 12.2% of iSpecimen shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Token Cat beats iSpecimen on 6 of the 11 factors compared between the two stocks.

How does iSpecimen compare to MOGU?

iSpecimen (NASDAQ:ISPC) and MOGU (NYSE:MOGU) are both small-cap business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability, media sentiment and risk.

MOGU has higher revenue and earnings than iSpecimen.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iSpecimen	$1.93M	2.05	-$10.49M	-$72.26	N/A
MOGU	$19.46M	0.70	-$8.62M	N/A	N/A

MOGU has a net margin of 0.00% compared to iSpecimen's net margin of -1,080.16%. MOGU's return on equity of 0.00% beat iSpecimen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iSpecimen	-1,080.16%	-584.65%	-142.48%
MOGU	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iSpecimen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
MOGU	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

13.6% of iSpecimen shares are held by institutional investors. Comparatively, 19.1% of MOGU shares are held by institutional investors. 12.2% of iSpecimen shares are held by company insiders. Comparatively, 19.8% of MOGU shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

iSpecimen has a beta of 1.62, meaning that its share price is 62% more volatile than the broader market. Comparatively, MOGU has a beta of 0.52, meaning that its share price is 48% less volatile than the broader market.

In the previous week, iSpecimen had 2 more articles in the media than MOGU. MarketBeat recorded 2 mentions for iSpecimen and 0 mentions for MOGU. iSpecimen's average media sentiment score of 0.44 beat MOGU's score of 0.00 indicating that iSpecimen is being referred to more favorably in the media.

Company	Overall Sentiment
iSpecimen	Neutral
MOGU	Neutral

Summary

MOGU beats iSpecimen on 7 of the 11 factors compared between the two stocks.

Get iSpecimen News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ISPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ISPC vs. The Competition

Export

Metric	iSpecimen	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$3.96M	$8.91B	$6.74B	$12.07B
Dividend Yield	N/A	1.71%	2.67%	5.67%
P/E Ratio	-0.04	24.87	24.21	24.42
Price / Sales	2.05	17.49	512.04	109.94
Price / Cash	N/A	13.73	27.48	37.92
Price / Book	0.19	5.53	10.66	6.83
Net Income	-$10.49M	$179.69M	$3.57B	$337.67M
7 Day Performance	-6.78%	1.54%	0.58%	1.17%
1 Month Performance	-33.73%	10.04%	1.54%	3.16%
1 Year Performance	-93.51%	5.88%	25.40%	30.58%

iSpecimen Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ISPC iSpecimen	0.3525 of 5 stars	$2.75 flat	N/A	-93.5%	$3.96M	$1.93M	N/A	60	Short Interest Increase
MGIH Millennium Group International	1.0971 of 5 stars	$1.69 +15.0%	N/A	-6.4%	$16.54M	$25.33M	N/A	792	Positive News Short Interest Decrease Gap Up High Trading Volume
IPM Intelligent Protection Management	2.1846 of 5 stars	$1.81 +0.6%	N/A	-7.0%	$16.26M	$23.61M	N/A	20
TGHL GrowHub	N/A	$0.52 -16.5%	N/A	N/A	$15.69M	$60K	N/A	12	Gap Down
TC Token Cat	1.0405 of 5 stars	$9.21 +6.8%	N/A	-40.7%	$14.92M	$850K	N/A	620	Positive News Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ISPC) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

iSpecimen (ISPC) Competitors

ISPC vs. MGIH, IPM, TGHL, TC, and MOGU

How does iSpecimen compare to Millennium Group International?

Summary

How does iSpecimen compare to Intelligent Protection Management?

Summary

How does iSpecimen compare to GrowHub?

Summary

How does iSpecimen compare to Token Cat?

Summary

How does iSpecimen compare to MOGU?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ISPC vs. The Competition

iSpecimen Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

iSpecimen (ISPC) Competitors

ISPC vs. MGIH, IPM, TGHL, TC, and MOGU

How does iSpecimen compare to Millennium Group International?

Is MGIH or ISPC more profitable?

Do analysts rate MGIH or ISPC?

Does the media refer more to MGIH or ISPC?

Which has higher valuation & earnings, MGIH or ISPC?

Which has more volatility and risk, MGIH or ISPC?

Do insiders and institutionals believe in MGIH or ISPC?

Summary

How does iSpecimen compare to Intelligent Protection Management?

Which has more volatility and risk, IPM or ISPC?

Do analysts prefer IPM or ISPC?

Do insiders & institutionals hold more shares of IPM or ISPC?

Is IPM or ISPC more profitable?

Does the media prefer IPM or ISPC?

Which has stronger valuation and earnings, IPM or ISPC?

Summary

How does iSpecimen compare to GrowHub?

Is ISPC or TGHL more profitable?

Which has preferable valuation & earnings, ISPC or TGHL?

Do analysts prefer ISPC or TGHL?

Does the media prefer ISPC or TGHL?

Do insiders & institutionals hold more shares of ISPC or TGHL?

Summary

How does iSpecimen compare to Token Cat?

Is TC or ISPC more profitable?

Do analysts prefer TC or ISPC?

Which has more volatility and risk, TC or ISPC?

Which has preferable earnings & valuation, TC or ISPC?

Does the media refer more to TC or ISPC?

Do institutionals & insiders believe in TC or ISPC?

Summary

How does iSpecimen compare to MOGU?

Which has better earnings and valuation, ISPC or MOGU?

Is ISPC or MOGU more profitable?

Do analysts recommend ISPC or MOGU?

Do institutionals and insiders hold more shares of ISPC or MOGU?

Which has more volatility and risk, ISPC or MOGU?

Does the media prefer ISPC or MOGU?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ISPC vs. The Competition

iSpecimen Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools